Kayne Anderson Rudnick Investment Management LLC Trims Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Kayne Anderson Rudnick Investment Management LLC lowered its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 9.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,192,832 shares of the company’s stock after selling 131,046 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned about 0.08% of U.S. Physical Therapy worth $110,242,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Canada Pension Plan Investment Board bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $28,000. Innealta Capital LLC bought a new stake in U.S. Physical Therapy in the second quarter worth $30,000. Quest Partners LLC grew its stake in shares of U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after acquiring an additional 337 shares during the last quarter. Northwest Bank & Trust Co bought a new position in shares of U.S. Physical Therapy during the fourth quarter valued at $37,000. Finally, Ridgewood Investments LLC bought a new position in shares of U.S. Physical Therapy during the second quarter valued at $51,000.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH opened at $83.27 on Friday. The firm’s 50-day moving average price is $88.60 and its 200-day moving average price is $97.08. U.S. Physical Therapy, Inc. has a 52-week low of $78.08 and a 52-week high of $113.63. The company has a market cap of $1.26 billion, a PE ratio of 67.70, a PEG ratio of 4.11 and a beta of 1.39. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.28.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The firm had revenue of $167.19 million during the quarter, compared to analysts’ expectations of $163.34 million. During the same quarter last year, the business earned $0.76 earnings per share. The business’s quarterly revenue was up 10.4% on a year-over-year basis. As a group, analysts anticipate that U.S. Physical Therapy, Inc. will post 2.51 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Friday, August 23rd were given a dividend of $0.44 per share. The ex-dividend date was Friday, August 23rd. This represents a $1.76 annualized dividend and a yield of 2.11%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 143.09%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Barrington Research reiterated an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research note on Friday. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st.

Insiders Place Their Bets

In related news, Director Kathleen A. Gilmartin bought 2,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were bought at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the transaction, the director now owns 18,904 shares of the company’s stock, valued at $1,627,445.36. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at $580,635. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Kathleen A. Gilmartin bought 2,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were purchased at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the purchase, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. The disclosure for this purchase can be found here. Insiders own 1.70% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.